Table 2. Patient PBMC samples involved in proliferation assay.

Patient gender	Patient age (yr)	Disease duration (yr)	Disease activity	Lesional Area	1st degree relatives with vitiligo	Associated disease*
Female	49	0.5	Progressive	<1%	No	No
Female	45	20	Progressive	8%	Yes	HT
Male	27	16	Progressive	1%	Yes	No
Male	16	1	Progressive	<1%	No	No
Male	48	10	Progressive	10%	No	HT
Male	18	5	Progressive	8%	Yes	AR, Asthma

^*HT = Hashimoto's thyroiditis. AR = allergic rhinitis.